Our 2025 spring co-ops have been settling into their experiences across our organization! From working in the lab to the office, we are proud to offer our co-ops an immersive, valuable experience as they spend a semester with us.

We are proud to support this educational Coffee and Clinicians webinar hosted by @CGDAofAmerica on Advancing Transformative Therapies for CGD, featuring leading expert, Dr. Donald Kohn (@UCLA). Registration details can be found via this link:

Join Prime on Tuesday, January 14 at #JPM25 for an update from CEO Keith Gottesdiener on what's ahead in 2025. We look forward to connecting with many #geneediting colleagues, industry leaders and friends in San Francisco!

Prime's achievements thus far would not be possible without the dedication of everyone who has been a part of our journey. Our team's commitment to making next-generation medicines a reality for patients drives us each day. We are grateful for the advancements we've made this past year, and look forward to continuing to work towards impacting patients & families in 2025. Cheers!

Co-founder and Head of Prime Editing Platform Andrew Anzalone joined industry leaders at the Genome Editing Therapeutics Summit in Boston this week. Learn more below.

#WilsonDisease currently has no cure and requires lifelong treatment. Today, on #WilsonDiseaseAwarenessDay, we stand with those whose lives have been upended by this disease, and are proud to be working to offer improved treatment options to those in need. #WilsonDiseaseAwareness

We're headed to San Diego this week for #ASH24, where Associate Director Jack Heath will give an oral presentation on new research on Prime Editing's broad potential capabilities. Find details below and read the full abstract here.

We recently held our annual team Thanksgiving celebration! We use this time as an opportunity to gather together, enjoy a delicious potluck and express gratitude and appreciation for the strides we've made in 2024 towards delivering transformative medicines to patients. Wishing everyone a happy and restful Thanksgiving with their loved ones.

Prime CTO Ann Lee will join @GTResearchNews at their upcoming Immunoengineering Industry Symposium to give a keynote presentation on Prime Editing. Learn more about the event here.

Members of Prime management will participate in a number of investor conferences in November. More details below. Learn more here. $PRME

We had polar seltzers, a heavy metal rock band, a wizard, among many others, join us in our office yesterday to celebrate Halloween! The Prime team got together to enjoy too much candy and carve pumpkins. Check it out.

East End House (@EEHCookingCause) works to promote the well-being, academic achievement & successful transition to adulthood of youth from under-resourced families in Cambridge. Prime team members recently spent an afternoon volunteering in EEH's food pantry department to help serve our neighbors in need. We are grateful for chances to make an impact in our local Kendall Square community.

Today, we will present in vivo proof-of-concept data highlighting interim preclinical advances in Wilson's Disease and the broad potential of our universal liver-targeted LNP for precise delivery of Prime Editors to correct disease-causing mutations in the liver at #ESGCT2024. CSO Jeremy Duffield shares more below. Learn more: $PRME

We are pleased to announce we will highlight advances from across our Prime Editing pipeline and platform at the upcoming #ESGCT2024 and #TLM24 meetings. CSO Jeremy Duffield shares insight into the importance of these data, especially our #WilsonsDisease program. Find full presentation details: $PRME

This weekend, Team Prime rode in the @CF_Foundation's Cycle for Life with one of the largest sponsored teams! With a few seasoned riders and many new riders, our team had a blast riding for this cause in support of the 30,000+ people in the U.S. with #cysticfibrosis.

Prime leaders Keith Gottesdiener and Mohammed Asmal are headed to Arizona this week for @alliancerm's #CGMesa24 to connect with industry peers on the latest in #genetherapy. Details on their sessions below.

Head of Stem Cell Biology Naqi Haider will present at the #iPSC Drug Development & Manufacturing Summit this week! Find details about his presentation and this exciting event on their website. 

Today, we announced a strategically updated pipeline, focused on a set of high value programs: hematology, immunology & oncology, liver and lung. CEO Keith Gottesdiener shares insight below. More:

We're excited to announce a strategic research collaboration & license agreement with @bmsnews to develop & commercialize ex vivo #Tcell therapies, allowing us the opportunity to apply Prime Editing technology beyond rare genetic diseases. Details:

Prime management looks forward to participating in a number of investor conferences throughout September. Live audio webcasts of each presentation will be available under “Events & Presentations” in the News & Events section of our website. Details: $PRME